Gabriel Figueroa-Parra
Articles
-
Jan 10, 2024 |
lupus.bmj.com | Gabriel Figueroa-Parra |Michael Putman |Cynthia S. Crowson |Alí Duarte-García
DiscussionIn this study of pivotal phase III, randomised, placebo-controlled trials of new treatments for SLE and LN, many trials had an important degree of fragility, even among RCTs of medications that obtained approval.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →